Page last updated: 2024-09-03

foropafant and dactinomycin

foropafant has been researched along with dactinomycin in 1 studies

Compound Research Comparison

Studies
(foropafant)
Trials
(foropafant)
Recent Studies (post-2010)
(foropafant)
Studies
(dactinomycin)
Trials
(dactinomycin)
Recent Studies (post-2010) (dactinomycin)
374119,045355969

Protein Interaction Comparison

ProteinTaxonomyforopafant (IC50)dactinomycin (IC50)
RAD51Homo sapiens (human)32.1
Growth factor receptor-bound protein 2Homo sapiens (human)5
Discoidin domain-containing receptor 2Homo sapiens (human)9
Growth factor receptor-bound protein 2 Mus musculus (house mouse)5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, GD; Guerrant, RL; Marcinkiewicz, M; Sarosiek, J; Thielman, NM1

Other Studies

1 other study(ies) available for foropafant and dactinomycin

ArticleYear
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
    The Journal of clinical investigation, 1997, Apr-15, Volume: 99, Issue:8

    Topics: Alprostadil; Animals; Bucladesine; Cell Size; CHO Cells; Cholera Toxin; Cricetinae; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Diterpenes; Ginkgolides; Humans; Lactones; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles

1997